Morepen Laboratories Limited (MOREPENLAB)

87.21

INR
+0.86(+1.00%)
As of December 6, 2024 10:00:00 AM

Morepen Laboratories Limited Share Price Information

24 hour Low and High

Low: 86.09
High: 88.3

All time High

7269.81

Price Change 1h

+₹0.86 +1.00%

Price Change 1d

+₹0.86 +1.00%

Price Change 1w

+₹11.60 +15.34%

Morepen Laboratories Limited Market Information

Exchange

NSE

Market Cap

4324.45 Cr

About Morepen Laboratories Limited Share

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

2152

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Morepen Laboratories Limited's (NSE:MOREPENLAB) largest shareholders are retail investors who were rewarded as market cap surged ₹6.0b last week
  • Morepen Lab rallies 8% in weak market; zooms 63% over QIP price in 1 month
  • Morepen Labs shares hit fresh one-year high as stock rallies 56% in a month; here's why
  • Morepen Labs stock hits 52-week high logging 15% intraday rally. More steam left? | Stock Market News
  • Morepen Lab Standalone September 2024 Net Sales at Rs 383.70 crore, up 0.64% Y-o-Y

FAQs

Morepen Laboratories Limited (MOREPENLAB)

87.21

INR
+0.86(+1.00%)
As of December 6, 2024 10:00:00 AM

Morepen Laboratories Limited Share Price Information

24 hour Low and High

Low: 86.09
High: 88.3

All time High

7269.81

Price Change 1h

+₹0.86 +1.00%

Price Change 1d

+₹0.86 +1.00%

Price Change 1w

+₹11.60 +15.34%

Morepen Laboratories Limited Market Information

Exchange

NSE

Market Cap

4324.45 Cr

About Morepen Laboratories Limited Share

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

2152

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Morepen Laboratories Limited's (NSE:MOREPENLAB) largest shareholders are retail investors who were rewarded as market cap surged ₹6.0b last week
  • Morepen Lab rallies 8% in weak market; zooms 63% over QIP price in 1 month
  • Morepen Labs shares hit fresh one-year high as stock rallies 56% in a month; here's why
  • Morepen Labs stock hits 52-week high logging 15% intraday rally. More steam left? | Stock Market News
  • Morepen Lab Standalone September 2024 Net Sales at Rs 383.70 crore, up 0.64% Y-o-Y

FAQs